Literature DB >> 21538359

MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.

Xiaofang Zhang1, Xiaojuan Wu, Juan Li, Yanlin Sun, Peng Gao, Cuijuan Zhang, Hui Zhang, Gengyin Zhou.   

Abstract

BACKGROUND AND OBJECTIVES: Besides MDR1/P-glycoprotein (MDR1/P-gp), glucosylceramide synthase (GCS), an enzyme, which transfers UDP-glucose to ceramide to form glucosylceramide was also related with multidrug resistance (MDR) in breast cancer. Although many research showed that GCS could affect mdr1 in cancer cells, nobody knows that whether mdr1 can affect GCS in breast cancer. Our study aims to verify that.
METHODS: A plasmid with multidrug resistence 1(mdr1) cDNA was transfected into the sensitive breast cancer cell line MCF-7, while an RNA interference (RNAi) vector targeted mdr1 was transfected into the MDR cell line MCF-7/ADM. Then RT-PCR, Western blot, MTT, and flow cytometry were used to assess the expression and function of mdr1 and GCS. RESULT: The data displayed that up-regulation of mdr1 could increase the expression of GCS, while the RNAi-expression plasmids could decrease that. Meantime, the changes of ceramide are opposed to that of GCS and are the same to the alteration of apoptosis rate.
CONCLUSIONS: Our results demonstrate that MDR1 could increase cellular apoptosis by regulating the expression of GCS in breast cancer cells.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538359     DOI: 10.1002/jso.21958

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Development of EGFR-targeted nanoemulsion for imaging and novel platinum therapy of ovarian cancer.

Authors:  Srinivas Ganta; Amit Singh; Niravkumar R Patel; Joseph Cacaccio; Yashesh H Rawal; Barbara J Davis; Mansoor M Amiji; Timothy P Coleman
Journal:  Pharm Res       Date:  2014-03-19       Impact factor: 4.200

Review 2.  Plant sterols as anticancer nutrients: evidence for their role in breast cancer.

Authors:  Bruce J Grattan
Journal:  Nutrients       Date:  2013-01-31       Impact factor: 5.717

3.  Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion.

Authors:  Mustafa A Kamani; Philippe Provençal; Michel Boutin; Natalia Pacienza; Xin Fan; Anton Novak; Tonny C Huang; Beth Binnington; Bryan C Au; Christiane Auray-Blais; Clifford A Lingwood; Jeffrey A Medin
Journal:  Future Sci OA       Date:  2016-10-13

Review 4.  The UDP-glucose ceramide glycosyltransferase (UGCG) and the link to multidrug resistance protein 1 (MDR1).

Authors:  Marthe-Susanna Wegner; Lisa Gruber; Peter Mattjus; Gerd Geisslinger; Sabine Grösch
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

5.  GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells.

Authors:  Jinshuai Shan; Yang Liu; Yukun Wang; Yimiao Li; Xiaochun Yu; Chen Wu
Journal:  Transl Oncol       Date:  2018-04-24       Impact factor: 4.243

6.  Rapamycin Antagonizes BCRP-Mediated Drug Resistance Through the PI3K/Akt/mTOR Signaling Pathway in mPRα-Positive Breast Cancer.

Authors:  Jing Zhang; Jing Hu; Weiwei Li; Chunyan Zhang; Peng Su; Yan Wang; Wei Sun; Xiao Wang; Li Li; Xiaojuan Wu
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

Review 7.  The Role of Sphingolipids Metabolism in Cancer Drug Resistance.

Authors:  Marina Bataller; Almudena Sánchez-García; Yoelsis Garcia-Mayea; Cristina Mir; Isabel Rodriguez; Matilde Esther LLeonart
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

8.  Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein.

Authors:  Britta Stordal; Marion Hamon; Victoria McEneaney; Sandra Roche; Jean-Pierre Gillet; John J O'Leary; Michael Gottesman; Martin Clynes
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.